Working Paper 191 | Experience of term assurances in 2022 (Issue date: 13/06/2024) |
Working Paper 182 | Considerations for term assurances post-pandemic (Issue date: 31/01/2024) |
Working Paper 176 | "All offices” experience of term assurances in 2021 (Issue date: 02/06/2023) |
Working Paper 170 | “All offices” experience of underwritten whole of life assurances, 2015-2019 (Issue Date: 28/02/2023) |
Working Paper 167 | Accelerated critical illness experience by cause of claim, 2017-2020 (Issue Date: 31/01/2023) |
Working Paper 162 | “All offices” experience of term assurances in 2020 (Issue date: 20/05/2022) |
Working Paper 154 | Final “16” Series term assurance mortality and accelerated critical illness tables (Issue Date: 31/08/2021) |
Working Paper 152 |
“All offices” experience of term assurances for 2015-2018 and 2019 plus indicative analysis of experience to mid-2020 (Issue date: 29/06/2021) |
Working Paper 151 |
Accelerated critical illness experience by cause of claim, 2015-2018 (Issue Date: 11/06/2021) |
Working Paper 150 | Proposed “16” Series term assurance mortality and accelerated critical illness tables (Issue Date: 30/04/2021; Response date: 30/06/2021) |
Working Paper 132 | “All offices” experience of term assurances, 2015-2018 (Issue date: 07/05/2020; v02 issue date: 29/04/2021; v03 issue date: 29/06/2021) |
Working Paper 125 | Additional analysis of the experience of term assurances, 2011-2016 (Issue date: 15/11/2019) |
Working Paper 123 |
"All offices” experience of term assurances, 2011-2016 (v01: issue date: 18/07/2019; v02 issue date: 07/05/2020) |
Working Paper 110 | Working Paper 110: Using the CMI Mortality Projections Model for assured lives (Issue date: 04/10/2018; Response date: 31/12/2018) |
Working Paper 108 | Interim “all offices” experience of term assurances, 2011-2015 (v01 issue date: 08/06/2018; v02 issue date: 07/05/2020; Response date: 12/07/2018) |
Working Paper 94 | Final "08" Series accelerated critical illness and term mortality tables (Issue date: 27/01/2017) |
Working Paper 92 | Proposed "08" Series term mortality tables (Issue Date: 07/10/2016; Response date: 30/11/2016) |
Proposed "08" Series accelerated critical illness tables (Issue date: 06/05/2016; Reissued: 07/10/2016; Response date: 30/11/2016) | |
All-Offices Mortality and Critical Illness Experience for the 2007-2010 Quadrennium (Issue date: 03/12/2014; Reissued: 01/02/2016) | |
A revised approach for analysing CMI critical illness experience and restated results for accelerated business, 2003-2006 (Issue date: 10/05/2013) | |
Supplementary analyses to CMI critical illness diagnosis rates for accelerated business, 2003-2006 | |
Cause-specific CMI critical illness diagnosis rates for accelerated business, 2003-2006 (Issue date: 15/06/2011) | |
CMI critical illness diagnosis rates for accelerated business 2003-2006 (Issue date: 24/01/2011) | |
CMI critical illness diagnosis rates for accelerated business 1999-2004 (Issue date: 12/02/2010) | |
The mortality of impaired assured lives: Report on 1995-2006 experience and consultation on the future of the investigation (Issue date: 14/01/2009) | |
A new methodology for analysing CMI critical illness experience (Issue date: 23/07/2008) | |
Progress towards an improved methodology for analysing CMI critical illness experience (Issue date: 27/07/2007) | |
1999-2002 critical illness experience: feedback on Working paper 14 and future work (Issue date: 01/12/2005) | |
Methodology underlying the 1999-2002 CMI critical illness experience investigation (Issue date: 05/05/2005) | |
The graduation of the CMI 1999-2002 mortality experience: feedback on Working paper 8 and proposed assured lives graduations (Issue date: 11/04/2005) |
Contact Details
If you have any questions about the CMI please email
Events calendar
No results found.